NVO : Novo Nordisk A/S stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-27 |
|---|---|---|---|---|
| 2023 | $88.4 | $85.79 | $90.77 | -3.59% |
| 2024 | $67.29 | $61.51 | $82.34 | -26.62% |
| 2025 | $77.02 | $65.83 | $83.89 | -16.01% |
| 2026 | $87.81 | $81.91 | $96.15 | -4.25% |
| 2027 | $97.13 | $96.38 | $97.77 | 5.92% |
| 2028 | $87.06 | $64.75 | $97.88 | -5.06% |
| 2029 | $56.56 | $53.78 | $61.3 | -38.32% |
| 2030 | $70.09 | $63.04 | $76.34 | -23.56% |
| 2031 | $66.28 | $56.98 | $84.08 | -27.72% |
| 2032 | $83.95 | $70.33 | $90.59 | -8.45% |
| 2033 | $61.75 | $59.81 | $67.17 | -32.66% |
The 1 Wall Street analysts offering Novo Nordisk A/S stock forecast in the last 6 months have average price target of
$31.0 with a high forecast of $31.0 and a low forecast of $31.0.
The average Novo Nordisk A/S stock forecast represents a -66.19%
decrease from the last price of $91.6999969482422.
From AI system, total return is 2366.52% from 4098 forecasts.
For Novo Nordisk A/S stock forecast for 2023, 3 predictions are offered for each month of 2023 with average Novo Nordisk A/S stock
forecast of $88.4, a high forecast of $90.77, and a low forecast of $85.79.
The average Novo Nordisk A/S stock forecast 2023 represents a -3.59%
decrease from the last price of $91.6999969482422.
For Novo Nordisk A/S stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Novo Nordisk A/S stock
forecast of $67.29, a high forecast of $82.34, and a low forecast of $61.51.
The average Novo Nordisk A/S stock forecast 2024 represents a -26.62%
decrease from the last price of $91.6999969482422.
For Novo Nordisk A/S stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Novo Nordisk A/S stock
forecast of $87.81, a high forecast of $96.15, and a low forecast of $81.91.
The average Novo Nordisk A/S stock forecast 2026 represents a -4.25%
decrease from the last price of $91.6999969482422.
For Novo Nordisk A/S stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Novo Nordisk A/S stock
forecast of $87.06, a high forecast of $97.88, and a low forecast of $64.75.
The average Novo Nordisk A/S stock forecast 2028 represents a -5.06%
decrease from the last price of $91.6999969482422.
For Novo Nordisk A/S stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Novo Nordisk A/S stock
forecast of $66.28, a high forecast of $84.08, and a low forecast of $56.98.
The average Novo Nordisk A/S stock forecast 2031 represents a -27.72%
decrease from the last price of $91.6999969482422.
For Novo Nordisk A/S stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average Novo Nordisk A/S stock
forecast of $61.75, a high forecast of $67.17, and a low forecast of $59.81.
The average Novo Nordisk A/S stock forecast 2033 represents a -32.66%
decrease from the last price of $91.6999969482422.
Please, see more forecasts below.
NVO : Novo Nordisk A/S stock forecast by Wall Street Analysts
The average Novo Nordisk A/S stock forecast from last 6 month is $31.0, and this show a 55.0% increase in average from the prior price target of the each prediction. Also, this average forecast of $31.0 represents a -78.62% decrease from the past average forecast of $145.0, 6 months ago from 1 wall street analysts.
Novo Nordisk A/S stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-29 | $91.20 | -0.55% |
| 2023-10-02 | $90.33 | -0.95% |
| 2023-10-03 | $89.54 | -0.87% |
| 2023-10-04 | $88.63 | -1.02% |
| 2023-10-05 | $89.40 | 0.87% |
NVO : Long term Novo Nordisk A/S stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $90.77 , for 2024 Sep. is $61.51 , for 2027 Sep. is $97.52 , for 2028 Sep. is $81.31 , for 2032 Sep. is $80.48 , and for 2033 Sep. is $60.87.
NVO : Novo Nordisk A/S stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $90.77 | -1.02% |
| 2023 Nov. | $88.66 | -2.33% |
| 2023 Dec. | $85.79 | -3.24% |
NVO : Novo Nordisk A/S stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $82.34 | -4.01% |
| 2024 Feb. | $78.26 | -4.96% |
| 2024 Mar. | $73.74 | -5.78% |
| 2024 Apr. | $69.49 | -5.75% |
| 2024 May. | $66.11 | -4.88% |
| 2024 Jun. | $63.71 | -3.62% |
| 2024 Jul. | $62.26 | -2.27% |
| 2024 Aug. | $61.60 | -1.07% |
| 2024 Sep. | $61.51 | -0.15% |
| 2024 Oct. | $61.86 | 0.57% |
| 2024 Nov. | $62.64 | 1.26% |
| 2024 Dec. | $63.99 | 2.15% |
NVO : Novo Nordisk A/S stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $65.83 | 2.88% |
| 2025 Feb. | $68.11 | 3.46% |
| 2025 Mar. | $70.66 | 3.75% |
| 2025 Apr. | $73.09 | 3.43% |
| 2025 May. | $75.26 | 2.98% |
| 2025 Jun. | $77.28 | 2.68% |
| 2025 Jul. | $79.23 | 2.52% |
| 2025 Aug. | $81.06 | 2.32% |
| 2025 Sep. | $82.68 | 2.00% |
| 2025 Oct. | $83.75 | 1.29% |
| 2025 Nov. | $83.89 | 0.17% |
| 2025 Dec. | $83.33 | -0.67% |
NVO : Novo Nordisk A/S stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $82.61 | -0.86% |
| 2026 Feb. | $82.05 | -0.68% |
| 2026 Mar. | $81.91 | -0.17% |
| 2026 Apr. | $82.36 | 0.55% |
| 2026 May. | $83.49 | 1.36% |
| 2026 Jun. | $85.33 | 2.21% |
| 2026 Jul. | $87.79 | 2.88% |
| 2026 Aug. | $90.19 | 2.74% |
| 2026 Sep. | $92.29 | 2.33% |
| 2026 Oct. | $94.09 | 1.95% |
| 2026 Nov. | $95.41 | 1.40% |
| 2026 Dec. | $96.15 | 0.77% |
NVO : Novo Nordisk A/S stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $96.38 | 0.24% |
| 2027 Feb. | $96.38 | 0.00% |
| 2027 Mar. | $96.45 | 0.08% |
| 2027 Apr. | $96.69 | 0.25% |
| 2027 May. | $97.00 | 0.32% |
| 2027 Jun. | $97.27 | 0.28% |
| 2027 Jul. | $97.44 | 0.18% |
| 2027 Aug. | $97.51 | 0.07% |
| 2027 Sep. | $97.52 | 0.01% |
| 2027 Oct. | $97.53 | 0.01% |
| 2027 Nov. | $97.61 | 0.09% |
| 2027 Dec. | $97.77 | 0.16% |
NVO : Novo Nordisk A/S stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $97.88 | 0.11% |
| 2028 Feb. | $97.75 | -0.13% |
| 2028 Mar. | $97.23 | -0.53% |
| 2028 Apr. | $96.29 | -0.97% |
| 2028 May. | $94.86 | -1.49% |
| 2028 Jun. | $92.79 | -2.18% |
| 2028 Jul. | $89.92 | -3.10% |
| 2028 Aug. | $86.10 | -4.24% |
| 2028 Sep. | $81.31 | -5.56% |
| 2028 Oct. | $75.78 | -6.81% |
| 2028 Nov. | $70.04 | -7.58% |
| 2028 Dec. | $64.75 | -7.55% |
NVO : Novo Nordisk A/S stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $60.39 | -6.73% |
| 2029 Feb. | $57.17 | -5.34% |
| 2029 Mar. | $55.10 | -3.61% |
| 2029 Apr. | $54.06 | -1.89% |
| 2029 May. | $53.78 | -0.52% |
| 2029 Jun. | $54.00 | 0.41% |
| 2029 Jul. | $54.54 | 1.00% |
| 2029 Aug. | $55.31 | 1.41% |
| 2029 Sep. | $56.30 | 1.80% |
| 2029 Oct. | $57.58 | 2.26% |
| 2029 Nov. | $59.22 | 2.85% |
| 2029 Dec. | $61.30 | 3.52% |
NVO : Novo Nordisk A/S stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $63.85 | 4.16% |
| 2030 Feb. | $66.73 | 4.51% |
| 2030 Mar. | $69.69 | 4.43% |
| 2030 Apr. | $72.54 | 4.10% |
| 2030 May. | $74.96 | 3.33% |
| 2030 Jun. | $76.34 | 1.85% |
| 2030 Jul. | $75.92 | -0.55% |
| 2030 Aug. | $73.63 | -3.01% |
| 2030 Sep. | $70.80 | -3.85% |
| 2030 Oct. | $68.10 | -3.81% |
| 2030 Nov. | $65.52 | -3.79% |
| 2030 Dec. | $63.04 | -3.79% |
NVO : Novo Nordisk A/S stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $60.73 | -3.66% |
| 2031 Feb. | $58.76 | -3.25% |
| 2031 Mar. | $57.39 | -2.32% |
| 2031 Apr. | $56.98 | -0.71% |
| 2031 May. | $57.96 | 1.72% |
| 2031 Jun. | $60.98 | 5.21% |
| 2031 Jul. | $64.34 | 5.51% |
| 2031 Aug. | $67.52 | 4.94% |
| 2031 Sep. | $71.23 | 5.49% |
| 2031 Oct. | $75.46 | 5.94% |
| 2031 Nov. | $79.92 | 5.92% |
| 2031 Dec. | $84.08 | 5.20% |
NVO : Novo Nordisk A/S stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $87.40 | 3.95% |
| 2032 Feb. | $89.57 | 2.48% |
| 2032 Mar. | $90.59 | 1.13% |
| 2032 Apr. | $90.58 | -0.01% |
| 2032 May. | $89.74 | -0.93% |
| 2032 Jun. | $88.20 | -1.72% |
| 2032 Jul. | $86.07 | -2.41% |
| 2032 Aug. | $83.47 | -3.02% |
| 2032 Sep. | $80.48 | -3.58% |
| 2032 Oct. | $77.20 | -4.08% |
| 2032 Nov. | $73.75 | -4.47% |
| 2032 Dec. | $70.33 | -4.64% |
NVO : Novo Nordisk A/S stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $67.17 | -4.49% |
| 2033 Feb. | $64.46 | -4.04% |
| 2033 Mar. | $62.32 | -3.32% |
| 2033 Apr. | $60.85 | -2.36% |
| 2033 May. | $60.05 | -1.31% |
| 2033 Jun. | $59.81 | -0.40% |
| 2033 Jul. | $59.94 | 0.22% |
| 2033 Aug. | $60.31 | 0.61% |
| 2033 Sep. | $60.87 | 0.93% |
Frequently Asked Questions about Novo Nordisk A/S stock forecast
Is Novo Nordisk A/S a good long term stock?
From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2023 Oct. is $90.7681868253722 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2024 Sep. is $61.510636262112 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock can be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2027 Sep. is $97.5163517341453 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2028 Sep. is $81.3124581200159 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2032 Sep. is $80.4835880961299 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2033 Sep. is $60.8683892009471
Is Novo Nordisk A/S stock overvalued?
Novo Nordisk A/S (NVO) stock is expected to go DOWN . Therefore, Tudal would say that Novo Nordisk A/S (NVO) stock is overvalued.
Will Novo Nordisk A/S stock price go up?
No. The Novo Nordisk A/S stock price forecast for 2024 Sep. is $61.510636262112
Is Novo Nordisk A/S stock a good buy now?
Since closing price on 2023-09-27 is $91.6999969482422 and forecast for 2024 Sep. is $61.51, Novo Nordisk A/S stock is not a good 1 year investment.